| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC2690 | |||||||||||||||||||||||
| Submitter : | Ms. Jillian Everett | Date & Time: | 12/06/2006 09:12:03 | |||||||||||||||||||||
| Organization : | Ms. Jillian Everett | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| I strongly feel that the use of aborted fetal cell line for future vaccines is a disgrace. It would present our nation as unethical and emphasize the decline of our society. | ||||||||||||||||||||||||